Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Sexually Transmitted Infections01:26

Sexually Transmitted Infections

1.5K
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
1.5K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

6.5K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.5K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

5.9K
5.9K
Cancer Vaccines01:30

Cancer Vaccines

1.2K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.2K
Viral Recombination00:57

Viral Recombination

25.5K
Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
25.5K
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

7.1K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
7.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hyperammonemia syndrome due to <i>Pluralibacter gergoviae</i> bacteremia in an immunocompromised patient: case report.

ASM case reports·2026
Same author

Translocation of bacteria from the gut to the brain in mice.

PLoS biology·2026
Same author

Claudin 4 Deletion Improves Gut Permeability and Survival in a Murine Model of Abdominal Sepsis.

Shock (Augusta, Ga.)·2026
Same author

Metagenomic next-generation sequencing reveals cross-reactivity of lateral flow cryptococcal antigen assay with <i>Trichosporon inkin</i>.

ASM case reports·2026
Same author

Rapid colorimetric antimicrobial susceptibilities direct from positive blood culture for Gram-negative bacteria.

Microbiology spectrum·2025
Same author

Microbiota Transplantation Among Patients Receiving Long-Term Care: The Sentinel REACT Nonrandomized Clinical Trial.

JAMA network open·2025
Same journal

Dietary supplementation with fermented compound Chinese herbal medicine reshapes the gastrointestinal microbiota and enhances growth in suckling lambs.

Microbiology spectrum·2026
Same journal

Prevalence and genotypic distribution of virulence factor genes and antibiotic susceptibility profiles in clinical <i>Pseudomonas aeruginosa</i> isolates from a public hospital in Nanyang, China.

Microbiology spectrum·2026
Same journal

Ammonium ion concentration-dependent production of extracellular polysaccharides from glycerol by an oleaginous yeast: visualization of the producer cells.

Microbiology spectrum·2026
Same journal

Characterization of <i>Klebsiella</i> phages PMBT12, PMBT63, and PMBT64 with functional insights into a Hoc-like, mucin-interacting protein of phage PMBT63.

Microbiology spectrum·2026
Same journal

Immune evasion, infectivity, and membrane fusion of SARS-CoV-2 variants LP.8.1.1, XEC.25.1, XFG, and NB.1.8.1.

Microbiology spectrum·2026
Same journal

Metabolomics profiling reveals changes in peptidoglycan and redox metabolism between ancient and modern <i>Mycobacterium tuberculosis</i>.

Microbiology spectrum·2026
See all related articles

Related Experiment Video

Updated: Mar 13, 2026

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
10:26

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

Published on: March 11, 2014

28.4K

Human Papillomavirus.

Eileen M Burd1,2, Christina L Dean1

  • 1Emory University School of Medicine, Department of Pathology and Laboratory Medicine, Atlanta, GA 30322.

Microbiology Spectrum
|October 12, 2016
PubMed
Summary
This summary is machine-generated.

Individuals with compromised immune systems face higher risks from human papillomavirus (HPV) infections. Persistent HPV in immunosuppressed individuals increases cancer risk, necessitating targeted screening and diagnostic approaches.

More Related Videos

Use of Interferon-&#947; Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
13:41

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

13.1K
Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
06:57

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

11.4K

Related Experiment Videos

Last Updated: Mar 13, 2026

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
10:26

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

Published on: March 11, 2014

28.4K
Use of Interferon-&#947; Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
13:41

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

13.1K
Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
06:57

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

11.4K

Area of Science:

  • Immunology
  • Oncology
  • Virology

Background:

  • Individuals with inherited immunodeficiencies, autoimmune disorders, organ/bone marrow transplants, or HIV are at increased risk for human papillomavirus (HPV) infections.
  • Chronic immunosuppression creates an environment conducive to persistent HPV infection, elevating the risk of malignant transformation.
  • Screening guidelines exist for cancers with detectable premalignant lesions (e.g., anal, cervical cancer).

Purpose of the Study:

  • To highlight the increased risk of HPV infection and associated malignant transformation in immunocompromised individuals.
  • To discuss diagnostic challenges and approaches for HPV-related lesions in various anatomic locations.

Main Methods:

  • Review of existing literature on HPV infection in immunocompromised populations.
  • Analysis of diagnostic methods for HPV-related lesions, including cytologic, histologic, and molecular techniques.
  • Discussion of screening guideline disparities across different anatomic sites.

Main Results:

  • Immunosuppressed individuals are susceptible to both low-risk and high-risk HPV types.
  • Persistent HPV infection in this population significantly increases cancer risk.
  • Diagnosis for cutaneous, penile, and oropharyngeal HPV lesions typically requires biopsy of suspicious lesions.

Conclusions:

  • Targeted screening and early diagnosis are crucial for managing HPV in immunocompromised patients.
  • Further research may be needed to develop effective screening strategies for anatomic locations lacking clear guidelines.
  • Accurate diagnostic methods are essential for timely detection and management of HPV-related malignancies.